Document is current
Any future updates will be listed below
-
Authors
Hu, Zheng
Ding, Jie
Ma, Zhicheng
Sun, Ruping https://orcid.org/0000-0003-3702-9483
Seoane, Jose A. https://orcid.org/0000-0002-3856-9177
Scott Shaffer, J.
Suarez, Carlos J.
Berghoff, Anna S.
Cremolini, Chiara
Falcone, Alfredo
Loupakis, Fotios
Birner, Peter
Preusser, Matthias https://orcid.org/0000-0003-3541-2315
Lenz, Heinz-Josef
Curtis, Christina https://orcid.org/0000-0003-0166-3802
- License Information
-
More Information
Article History
Received: 21 December 2018
Accepted: 18 April 2019
First Online: 17 June 2019
Competing interests
: A.S.B. has received research support from Daiichi Sankyo and honoraria for lectures, consultation or advisory board participation from Roche Bristol-Myers Squibb, Merck and Daiichi Sankyo as well as travel support from Roche, Amgen and AbbVie. M.P. has received honoraria for lectures, consultation or advisory board participation from the following for-profit companies: Bayer, Bristol-Myers Squibb, Novartis, Gerson Lehrman Group, CMC Contrast, GlaxoSmithKline, Mundipharma, Roche, Astra Zeneca, AbbVie, Lilly, Medahead, Daiichi Sankyo and Merck Sharp & Dome. P.B. has received travel support, honoraria for lectures, consultation or advisory board participation from the following for-profit companies: Biocartis, Novartis, Pfizer, Roche and Roche Diagnostics. C. Curtis is a scientific advisor to GRAIL and reports stock options as well as consulting for GRAIL and Genentech.
